A Trial to Investigate the Safety, Tolerability, and Drug Levels in Blood After Single and Multiple Doses of LEO 32731 in Healthy People

NCT03812198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LEO 32731 modified release tablet
DRUG: LEO 32731 blend, hard capsule
DRUG: LEO 32731 API, hard capsule
DRUG: LEO 32731 soft capsule
DRUG: LEO 32731 gastro-resistant capsule
DRUG: LEO 32731
OTHER: Placebo

Sponsor

LEO Pharma